TrialClinical drug investigation2026

A Study on the Safety, Pharmacokinetics, and Pharmacodynamics of H018 Tablets, a Selective JAK1 Inhibitor, Upon Single- and Multiple-Dose Administration in Chinese Healthy Subjects.

Juan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.